Organisms | Evidence |
---|---|
Ovis aries (sheep) | |
Cricetulus griseus (Chinese hamster) | |
Mus musculus (house mouse) | |
Bos taurus (domestic cattle) | |
Escherichia coli |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
C1GALT1 | (not applicable) |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC1 | CMP-Neu5Ac |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC1 | CMP-Neu5Ac |
|
O-glycan Synthesis |
|
O-glycan Synthesis | |
B3GNT6 | UDP-GlcNAc |
|
[alpha]-pNP |
|
[alpha]-pNP |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
C1GALT1 | (not applicable) |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC1 | CMP-Neu5Ac |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC4 | CMP-Neu5Ac |
|
benzyl |
|
benzyl | |
ST6GALNAC1 | CMP-Neu5Ac |
|
O-glycan Synthesis |
|
O-glycan Synthesis | |
ST6GALNAC1 | CMP-Neu5Ac |
|
[Ala-Thr(*)-Ala]2-7 |
|
[Ala-Thr(*)-Ala]2-7 |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Reference |
---|---|---|---|---|
B4GALT3 | UDP-Gal |
|
Benzyl-[alpha] | |
B4GALT4 | UDP-Gal |
|
[alpha]-1-Benzyl | |
B4GALNT4 | UDP-GalNAc |
|
[alpha]-Bz | |
B3GALNT2 | UDP-GalNAc |
|
[alpha]-Bz | |
B3GALNT2 | UDP-GalNAc |
|
[beta]-pNP |
UniProt ID | Protein Name | Reference | Source |
---|---|---|---|
Q9Y2G1 | Myelin regulatory factor | ||
Q9Y4C4 | Malignant fibrous histiocytoma-amplified sequence 1 | ||
Q9Y4L1 | Hypoxia up-regulated protein 1 | ||
Q9Y520 | Protein PRRC2C | ||
Q9Y5L2 | Hypoxia-inducible lipid droplet-associated protein | ||
Q9Y5M8 | Signal recognition particle receptor subunit beta | ||
Q9Y5T4 | DnaJ homolog subfamily C member 15 | ||
Q9Y5X9 | Endothelial lipase | ||
Q9Y5Y6 | Suppressor of tumorigenicity 14 protein | ||
Q9Y5Z0 | Beta-secretase 2 |
Pathway Name | Organism |
---|---|
E.coli O101 | Escherichia coli |
E.coli O103 | Escherichia coli |
E.coli O107 | Escherichia coli |
E.coli O112ab | Escherichia coli |
E.coli O112ac | Escherichia coli |
E.coli O116 | Escherichia coli |
E.coli O117 | Escherichia coli |
E.coli O125ab | Escherichia coli |
E.coli O127 | Escherichia coli |
E.coli O128ab-H27 | Escherichia coli |
RES 1b:a-dgal-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
PubMed ID | Title | First Author | Publication Date | Source |
---|---|---|---|---|
32502344 | Dual-Probe Approach for Mass Spectrometric Quantification of MUC1-Specific Terminal Gal/GalNAc In Situ | Sun B | 2020 Jun 05 |
|
32119947 | H-type lectins – Structural characteristics and their applications in diagnostics, analytics and drug delivery | Pietrzyk-Brzezinska AJ | 2020 Jun 01 |
|
32726826 | The Evolution of Hemophilia Care: Clinical and Laboratory Advances, Opportunities, and Challenges | Trinchero A | 2020 Jul 29 |
|
32578997 | Cysteine Aminoethylation Enables the Site-Specific Glycosylation Analysis of Recombinant Human Erythropoietin using Trypsin | Lippold S | 2020 Jul 21 |
|
32681153 | Large-scale site-specific mapping of the O-GalNAc glycoproteome | Yang W | 2020 Jul 17 |
|
32535887 | Bariatric surgery decreases oxidative stress and protein glycosylation in patients with morbid obesity | Carmona-Maurici J | 2020 Jul 13 |
|
32005975 | C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer | Lee PC | 2020 Jan 31 |
|
31932717 | Molecular basis for fibroblast growth factor 23 O-glycosylation by GalNAc-T3 | de las Rivas M | 2020 Jan 13 |
|
32161592 | Activation of the C-Type Lectin MGL by Terminal GalNAc Ligands Reduces the Glycolytic Activity of Human Dendritic Cells | Zaal A | 2020 Feb 25 |
|
32034693 | Givosiran: First Approval | Scott LJ | 2020 Feb 08 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.2.1
Last updated: April 7, 2025